Skip to content

Evaluation of a program to improve access to health among cocoa farmers in Côte d'Ivoire

Evaluation of a program to improve access to health among cocoa farmers in Côte d'Ivoire - ELUCID-CDI

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00038605
Enrollment
1600
Registered
2026-01-21
Start date
2025-12-08
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Access to health services

Interventions

Group 1: Elucid Santé, a non-profit organisation in Côte d'Ivoire, collaborates with cocoa cooperatives in Tony's Chocolonely's supply chain to provide members of these cooperatives with improved acce

Sponsors

Charité Centre for Global Health
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Cocoa farmers who are at least 18 years old and members of participating cooperatives are eligible for the interview.

Exclusion criteria

Exclusion criteria: Individuals who are younger than 18 years or who do not give consent, are excluded. Individuals who cannot participate in the interview for health or language-related reasons, are also excluded.

Design outcomes

Primary

MeasureTime frame
1. Productivity (volume of cocoa beans produced) 2. Use of healthcare facilities All outcomes are measured using a quantitative data collection among cocoa farmers that will be conducted both before and after the introduction of the Elucid program.

Secondary

MeasureTime frame
1. Income 2. Out-of-pocket health expenses 3. Occurrence of catastrophic health expenditures 4. Health (days not worked due to illness) 5. Membership in cooperatives that participate in the Elucid program

Countries

Côte d’Ivoire

Contacts

Public ContactLisa Bogler

Charité Centre for Global Health

lisa.bogler@charite.de+493045050

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026